Financial Synergies Wealth Advisors, Inc. Merck & Co., Inc. Transaction History

Financial Synergies Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$113.24 - $131.95 $56,053 - $65,315	495 Added 82.78%	1,093 $144 Million
Q4 2023 Apr 04, 2024	SELL	$100.18 - $109.02 $39,270 - $42,735	-392 Reduced 39.6%	598 $66.3 Million
Q3 2023 Apr 04, 2024	SELL	$102.95 - $114.33 $13,486 - $14,977	-131 Reduced 11.69%	990 $102 Million
Q2 2023 Apr 04, 2024	BUY	$108.61 - $118.38 $217 - $236	2 Added 0.18%	1,121 $129 Million
Q1 2023 Apr 04, 2024	BUY	$102.94 - $114.86 $53,631 - $59,842	521 Added 87.12%	1,119 $119 Million
Q4 2022 Apr 04, 2024	BUY	$87.44 - $112.11 $22,821 - $29,260	261 Added 77.45%	598 $66.3 Million
Q3 2022 Apr 04, 2024	BUY	$84.53 - $94.96 $11,580 - $13,009	137 Added 68.5%	337 $29 Million
Q2 2022 Apr 04, 2024	BUY	$83.49 - $94.64 $16,698 - $18,928	200 New	200 $18.2 Million

3,826

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.